<DOC>
	<DOCNO>NCT01053364</DOCNO>
	<brief_summary>The purpose study evaluate clinical safety feasibility NL-Prow™ Interspinous Spacer implant insertion procedure treatment lumbar spinal stenosis</brief_summary>
	<brief_title>Feasibility Study NL-Prow Interspinous Spacer Treat Lumbar Spinal Stenosis</brief_title>
	<detailed_description />
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Spinal Stenosis</mesh_term>
	<criteria>Men woman ≥50 year age . Symptoms leg/buttock/groin pain , without back pain , exacerbate lumbar extension relieve flexion . Diagnosis neurogenic intermittent claudication ( NIC ) ( define feeling paresthesia and/or discomfort and/or pain and/or weakness leg ( ) walk stand ) secondary lumbar spinal canal stenosis 12 lumbar level ( L1 L5 ) , confirm dynamic XRay ( show sagital instability rock ) , CT and/or MRI ( show central spinal canal narrow and/or foraminal narrowing ) . Has complete least 6 month conservative therapy , may include limited , epidural steroid injection , oral steroid , NSAIDS , analgesic , physical therapy , spinal manipulation , brace . Appropriate candidate lumbar surgical treatment use posterior approach . Subject walk independently 15 meter . Subject able understand risk benefit participate study . Subject understands sign study inform consent form . Subject physically mentally willing able comply requirement study procedure schedule followup visit test . Severe symptomatic lumbar spinal stenosis ≥2 level , require surgical intervention . Prior lumbar spine surgery level . Unremitting pain spinal position axial back pain without leg/buttock/groin pain . Evidence subject 's symptom due vascular claudication OR significant peripheral vascular disease . Significant instability lumbar spine level OR define translation 3mm 10 degree angular motion flexion extension upright lateral radiograph . Subject ankylose segment affect level . Significant scoliosis , define Cobb angle &gt; 25° . Cauda equina syndrome . Fixed motor deficit know peripheral neuropathy demonstrate clinically . Subject degenerative neurologic disease . Subject mass lesion . Any evidence spinal systemic infection . Subject history spinous process fracture par interarticularis fracture pathologic fracture vertebrae multiple fracture vertebrae and/or hip Subject history radiographic evidence 1 osteoporotic fracture spine . Subject severe osteoporosis spine , define bone mineral density ( BMD ) spine 2.5 SD mean adult normal . Subject paraparetic . Subject bleed disorder . Active systemic disease HIV , hepatitis , etc . Subject immunologically suppress , receive receive 7.5 milligram prednisone ( equivalent ) daily six month immediately prior enrollment . Extreme morbid obesity , define BMI &gt; 35 kg/m2 . Diagnosis lumbar spinal stenosis require direct neural decompression surgical intervention require implant experimental device . Subject able undergo MRI tolerate close MRI scan . Known suspected history alcohol and/or drug abuse . Life expectancy less one year . Active rheumatoid arthritis .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>